Endocrinologist Dr. Rekha Kumar discusses a new oral version of GLP-1 weight-loss drugs that does not require refrigeration or injections. Clinical trials show weight loss results comparable to injectables like Ozempic and Mounjaro, with a 16-pound average loss over 40 weeks. The hosts express skepticism about the long-term safety of these "pills for junk food" and advise listeners to stay away from the medication.
